Continued Respiratory Therapy Phone: 866-382-0799


How Does Mucus Clearance Differ Between Healthy Lungs And Those Affected By Cystic Fibrosis?

Prigi Varghese, MSN, APRN, CPNP-PC

January 1, 2026

Question

How does mucus clearance differ between healthy lungs and those affected by Cystic Fibrosis?

 

Answer

As this course is geared towards respiratory therapists, the respiratory system is one of the leading systems affected by CF. Mucus is essential in the lungs, where it traps germs and pollutants that we inhale. Cilia, tiny hairs on the outside of cells, propel mucus out of the lungs and into the throat, where it can be swallowed or coughed out.

However, in a Cystic Fibrosis lung, the mucus is thick and sticky. And therefore, it is very hard for cilia to sweep up the germs and particles from the lungs. As a result, the mucus clogs the airways making it difficult to breathe. Because the mucus in people with CF is also abnormal in other ways, it is less effective at killing germs than the mucus in healthy individuals, thus creating a fertile breeding ground for lung infections, inflammation, and damage. Other symptoms of CF in the respiratory system include hemoptysis, pneumothorax, clubbing of digits, hypoxia, mucus plugging, and bronchiectasis. 

This Ask the Expert is an edited excerpt from the course, Cystic Fibrosis: A Comprehensive Overviewpresented by Prigi Varghese, MSN, APRN, CPNP-PC. 


prigi varghese

Prigi Varghese, MSN, APRN, CPNP-PC

Prigi Varghese is a Nurse Practitioner with over 15 years of clinical experience. She received her Bachelor of Science in Nursing in 2004 and her Master of Science in Nursing in 2010 from Texas Woman's University in Dallas, Texas. Currently, she is the CF Program Coordinator & Quality Improvement Coordinator for the Pediatric Cystic Fibrosis Center at Children's Health.

Her dual roles in program development and quality improvement involve care coordination for 300+ pediatric patients, identifying high-risk populations with advocacy for follow-up services and support, department-specific initiatives, and process improvements. Her achievements include the 2016 Excellence and Accountability Cornerstone award for all Advanced Practitioners at Children's Health, the 2018 Quality Care Cornerstone Award, and the 2019 Dallas' Finest Award designated by the North Texas CF Foundation.

She is directly involved in various quality improvement initiatives through the CF Foundation and the CF Learning Network. In addition, she has presented on various topics related to Cystic Fibrosis both regionally and nationally.


Related Courses

Cystic Fibrosis: A Comprehensive Overview
Presented by Prigi Varghese, MSN, APRN, CPNP-PC
Video

Presenter

Prigi Varghese, MSN, APRN, CPNP-PC
Course: #2501Level: Intermediate1 Hour
  'Usefull onformation'   Read Reviews
Cystic Fibrosis is a complex diagnosis that affects multi-organ systems and requires management and care from a multidisciplinary team. This webinar addresses pathophysiology, diagnosis, management of pulmonary and non-pulmonary symptoms. Current and emerging cystic fibrosis therapies are discussed.

Respiratory Management of Patients With Neuromuscular Weakness Series: Review Recommendations and Best Practice
Presented by Duane Reed, EdD, RRT, RCP
Video

Presenter

Duane Reed, EdD, RRT, RCP
Course: #1827Level: Intermediate1 Hour
  'Vey easy to understand the topic and expectations were clear'   Read Reviews
An essential concern in neuromuscular diseases (NMD) is respiratory failure. This course reviews guidelines and evidenced-based literature on the best practice respiratory management of patients with NMD. It is part of an NMD series but can be viewed as a stand-alone learning experience.

Respiratory Management of Patients with Neuromuscular Weakness Series: Review of the Grading of Recommendations for Assessment, Development, and Evaluations
Presented by Duane Reed, EdD, RRT, RCP
Video

Presenter

Duane Reed, EdD, RRT, RCP
Course: #1846Level: Introductory1 Hour
  'Speaker kept my attention and seems to be very enthusiastic about what he is teaching'   Read Reviews
Clinical experts comprised a multi-professional panel to conduct a systematic review to address patients with neuromuscular diseases (NMD). A review of evidenced-based grading of recommendations and management of patients with NMD is discussed. It is part of an NMD series but can be viewed as a stand-alone learning experience.

Neuromuscular Disease Review/ Management, in partnership with Midwestern State University
Presented by Tammy Kurszewski, DHSc, RRT-ACCS, Jessica Fino, EdD, RRT
Audio

Presenters

Tammy Kurszewski, DHSc, RRT-ACCSJessica Fino, EdD, RRT
Course: #1641Level: Introductory2 Hours
  'The instructors were knowledgeable about the material and presented it in a clear manner'   Read Reviews
This course reviews neuromuscular diseases and associated treatment strategies within the scope of Respiratory Therapy. In addition, this course also discusses the importance of an interdisciplinary approach to caring for neuromuscular patients.

Identifying Long COVID in Clinical Practice: Would You Recognize It If You Saw It?
Presented by Jessica DeMars, BSc.P.T.
Video

Presenter

Jessica DeMars, BSc.P.T.
Course: #2186Level: Introductory1 Hour
  'very interesting'   Read Reviews
Respiratory therapists and rehabilitation providers working in a variety of settings in the community will likely encounter individuals living with Long COVID. This course provides clinicians with guidance on how Long COVID may present in their patients, how to screen for red flags, and what entails safe rehabilitation for this population based on current guidelines.